Silvio Veronese

Silvio Veronese

UNVERIFIED PROFILE

Are you Silvio Veronese?   Register this Author

Register author
Silvio Veronese

Silvio Veronese

Publications by authors named "Silvio Veronese"

Are you Silvio Veronese?   Register this Author

58Publications

2806Reads

48Profile Views

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.

Clin Colorectal Cancer 2017 09 25;16(3):e153-e163. Epub 2017 Jan 25.

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy; Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2017.01.004DOI Listing
September 2017

c.428T > C (p.V143A) homozygous mutation in TP53 gene as a possible mechanism of resistance to trastuzumab therapy in gastric cancer.

Acta Oncol 2016 Nov 31;55(11):1373-1375. Epub 2016 Aug 31.

e Molecular Pathology Unit, Department of Laboratory Medicine , Niguarda Cancer Center, ASST- Grande Ospedale Metropolitano Niguarda , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2016.1196828DOI Listing
November 2016

Clonal evolution and - coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer.

ESMO Open 2016 4;1(4):e000079. Epub 2016 Aug 4.

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy; Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://esmoopen.bmj.com/lookup/doi/10.1136/esmoopen-2016-000
Publisher Site
http://dx.doi.org/10.1136/esmoopen-2016-000079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070243PMC
August 2016

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.

J Natl Cancer Inst 2016 Jan 12;108(1). Epub 2015 Nov 12.

Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy (ASB, AA, EV, LP, EB, GM, SV, AV, SS); Nerviano Medical Sciences S.r.l Nerviano, Milan, Italy (EA, RB, AS, LR, PB, AL, RA, AG, AI); Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Torino, Italy (SM, AB); University of Torino, Department of Oncology, Candiolo, Torino, Italy (AB); FIRC Institute of Molecular Oncology (IFOM), Milano, Italy (SM); Ignyta, Inc., San Diego, CA (DL, ZH, JL); Clioss S.r.l. Nerviano, Milan, Italy (MM, CD); Università degli Studi di Milano, Milan, Italy (SS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712682PMC
January 2016

Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid.

Clin Lymphoma Myeloma Leuk 2016 Jan 2;16(1):e7-9. Epub 2015 Dec 2.

Department of Haematology, Niguarda Ca' Granda Hospital, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.11.004DOI Listing
January 2016

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

Int J Biol Markers 2015 Jul 22;30(3):e275-81. Epub 2015 Jul 22.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (Forlì-Cesena) - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/jbm.5000149DOI Listing
July 2015

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Blood 2015 Jan 17;125(5):856-9. Epub 2014 Dec 17.

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Greece; Hematology Department and Hematopoietic Cell Transplantation Unit, Georgios Papanicolaou Hospital, Thessaloniki, Greece;

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/bloodjournal/125/5/856.f
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-09-60
Publisher Site
http://dx.doi.org/10.1182/blood-2014-09-600874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311230PMC
January 2015

Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number.

Clin Cancer Res 2014 Feb 10;20(4):995-1006. Epub 2013 Dec 10.

Authors' Affiliations: Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori; Molecular Pathology Unit, Ospedale Niguarda Ca' Grande, Milan; and Sigma-Tau S.p.A., Pomezia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1684DOI Listing
February 2014

Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?

Clin Lymphoma Myeloma Leuk 2013 Aug 14;13(4):441-6. Epub 2013 Jun 14.

Department of Oncology/Hematology, Niguarda Ca' Granda Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.02.024DOI Listing
August 2013

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.

J Pathol 2009 Aug;218(4):478-86

Division of Hematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2555DOI Listing
August 2009

EGFR FISH in colorectal cancer: what is the current reality?

Lancet Oncol 2008 May;9(5):402-3

Falck Division of Medical Oncology, Niguarda Ca' Granda Hospital, 20162 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70109-8DOI Listing
May 2008

Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.

Haematologica 2002 Jul;87(7):695-700; discussion 700

Divisione di Ematologia, Dipartmento di Ematologia, Ospedale Niguarda Ca' Granda, piazza Ospedale Maggiore 3, 20162 Milan, Italy.

View Article

Download full-text PDF

Source
July 2002